ACQUIRED HEMOPHILIA A

被引:20
|
作者
Franchini, Massimo [1 ]
Lippi, Giuseppe [2 ]
机构
[1] Univ Hosp Parma, Dept Pathol & Lab Med, Immunohematol & Transfus Ctr, Parma, Italy
[2] Univ Hosp Parma, Clin Chem Lab, Dept Pathol & Lab Med, Parma, Italy
来源
ADVANCES IN CLINICAL CHEMISTRY, VOL 54 | 2011年 / 54卷
关键词
FACTOR-VIII; ANTIBODIES; RITUXIMAB; INACTIVATION; INHIBITORS; PROGNOSIS; DIAGNOSIS; KINETICS; BINDING; IGG;
D O I
10.1016/B978-0-12-387025-4.00003-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Acquired hemophilia A is a rare but often life-threatening hemorrhagic disorder characterized by an autoantibody directed against coagulation factor VIII. Fifty per cent of cases are idiopathic whereas the remaining 50% are associated with pregnancy, autoimmune conditions, malignancies and drugs. In this review the actual knowledge on diagnostic and therapeutic aspects of this disease will be summarized.
引用
收藏
页码:71 / 80
页数:10
相关论文
共 50 条
  • [1] Acquired hemophilia
    Garcia-Chavez, Jaime
    Majluf-Cruz, Abraham
    GACETA MEDICA DE MEXICO, 2020, 156 (01): : 65 - 75
  • [2] Acquired hemophilia in malignancy
    Reeves, Brandi N.
    Key, Nigel S.
    THROMBOSIS RESEARCH, 2012, 129 : S66 - S68
  • [3] Inhibitor eradication and treatment for acquired hemophilia A
    Franchini, Massimo
    Focosi, Daniele
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 233 - 240
  • [4] A study of 65 patients with acquired hemophilia A in Taiwan
    Huang, Shang-Yi
    Tsay, Woei
    Lin, Shyuann-Yuh
    Hsu, Szu-Chun
    Hung, Mei-Hwa
    Shen, Ming-Ching
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (04) : 321 - 327
  • [5] Hemostatic therapy as a management strategy for acquired hemophilia: what does the future hold?
    Franchini, Massimo
    Schiavulli, Michele
    Liumbruno, Giancarlo Maria
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (03) : 263 - 270
  • [6] Acquired Hemophilia A: A Case Report
    Shen, Mark
    Wang, Shan
    Sessa, Julia
    Hanna, Adel
    Axelrad, Alexander
    Ali, Fand
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (04) : 562 - 566
  • [7] Adequate diagnosis of acquired hemophilia A
    Casas Patarroyo, Claudia Patricia
    Agudelo Lopez, Claudia Del Pilar
    Galvez, Kenny
    Lagos Ibarra, Jimmy
    Rojas, Susan Martinez
    Bernal, Linda Ibata
    REVISTA MEDICA DE CHILE, 2019, 147 (03) : 334 - 341
  • [8] A case of acquired hemophilia A after pancreaticoduodenectomy for distal cholangiocarcinoma
    Takahashi, Makoto
    Morita, Yasuhiro
    Hayashi, Tatsuya
    Higashihara, Taku
    Kawasaki, Keishi
    Sato, Shunsuke
    Yokose, Shota
    Sasaki, Shu
    Funakoshi, Kaoruko
    Sasaki, Takayoshi
    Zhou, Daren
    Ichinose, Akinori
    Ohtsuka, Hideo
    Ishibashi, Yuji
    Hatao, Fumihiko
    Shimizu, Keiki
    Isono, Nobuo
    Sasaki, Naomi
    Kozai, Yasuji
    Okada, Haruka
    Chikasawa, Yushi
    BIOMEDICAL REPORTS, 2023, 19 (03)
  • [9] Emicizumab for the treatment of acquired hemophilia A
    Knoebl, Paul
    Thaler, Johannes
    Jilma, Petra
    Quehenberger, Peter
    Gleixner, Karoline
    Sperr, Wolfgang R.
    BLOOD, 2021, 137 (03) : 410 - 419
  • [10] Acquired Hemophilia A
    Pai, Menaka
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (06) : 1131 - 1142